OCULIS HOLDING AG
OCS·H5870P102·US·Common Stock·Healthcare - Biotechnology-13D/G
OCS (OCULIS HOLDING AG) is held by 36 institutional investors as of Q2 2026. Largest holders: Aberdeen Group plc ($30M), MILLENNIUM MANAGEMENT LLC ($28.3M), CITADEL ADVISORS LLC ($13.7M). Net institutional sentiment: Bullish.
36
Holders
$134.1M
Total Value
69% (39)
Consensus
27 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders none · Activists Apr 29, 2026 · Congress none
ActivistL7LSP 7 Cooperatieve U.A.11.8%Apr 29, 2026
ActivistBIBVCF IV, L.P.4.1%Mar 27, 2026
ActivistNFNan Fung Group Holdings Limited4.9%Nov 14, 2025
Top Holders
Checking access…
Showing 1-20 of 42
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer